By Abigail Townsend
Date: Wednesday 20 Oct 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
By Abigail Townsend
Date: Tuesday 08 Jun 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
By Alexander Bueso
Date: Friday 27 Nov 2020
(Sharecast News) - Biogen has inked a deal with Sage Therapeutics to jointly develop and sell potentially "breakthrough" treatments for major depressive and movement disorders in the US.
Currency | US Dollars |
Share Price | $ 133.13 |
Change Today | $ 2.77 |
% Change | 2.12 % |
52 Week High | $236.72 |
52 Week Low | $118.84 |
Volume | 1,166,151 |
Shares Issued | 145.80m |
Market Cap | $19,410m |
RiskGrade | 259 |
Strong Buy | 6 |
Buy | 8 |
Neutral | 21 |
Sell | 0 |
Strong Sell | 0 |
Total | 35 |
Time | Volume / Share Price |
16:00 | 191,213 @ $133.13 |
15:59 | 100 @ $133.16 |
15:59 | 100 @ $133.16 |
15:59 | 1,200 @ $133.16 |
15:59 | 100 @ $133.13 |
You are here: research